Registry for Hereditary Spastic Paraplegia to Support Future Treatments
Official title: STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
Run by IRCCS Fondazione Stella Maris · NCT06572046 · Data updated 2026-11-12
This study is creating a database to track people with hereditary spastic paraplegia over time to help understand the condition better and support future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | IRCCS Fondazione Stella Maris Academic / other |
| Locations | 1 site (Pisa) |
| Status | Recruiting |
| Started | January 24, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2029 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT06572046 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a clinical diagnosis of pure or complex hereditary spastic paraplegia, regardless of genetic diagnosis.
✕Probably not a fit
Patients with secondary forms of hereditary spastic paraplegia or significant comorbidities that affect their clinical picture may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to create a comprehensive database of patients affected by hereditary spastic paraplegia (HSP) to facilitate the collection and management of patient data over time. It will involve five clinical centers where participants will be assessed annually, allowing for the monitoring of disease progression and the development of clinical outcome measures. The registry will utilize validated clinical scales, biomarkers, and patient-reported outcomes to capture the phenotypic complexity of HSP. Biological samples will also be collected for future research and analysis.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of hereditary spastic paraplegia and pave the way for the development of targeted therapies.
How similar studies have gone: Other registries for rare diseases have shown success in facilitating research and improving patient outcomes, suggesting a positive outlook for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * clinical diagnosis of pure or complex HSP/spastic ataxia, even in the absence of a known genetic diagnosis * participants/parents/legal guardians will have to give informed consent for enrollment in the registry and privacy data management Exclusion Criteria: * subjects affected by secondary forms of HSP * presenting comorbidities that affect the general clinical picture according to clinical judgment * lack of informed consent
Where it's running
-
IRCCS Fondazione Stella Maris
Pisa, Italy Recruiting
Study contacts
- Principal investigator: Filippo M Santorelli, Dr. — IRCCS Fondazione Stella Maris
- Study coordinator: Filippo M Santorelli, Dr.
- Email: filippo.santorelli@fsm.unipi.it
- Phone: +39 050886275
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rare Disease Registry for Movement Disorders in Southern Anhui
This project is creating a registry to collect information from adults with motor neuron diseases, spinocerebellar ataxias, hereditary muscular dystrophy, or hereditary spastic paraplegia in Southern Anhui.
-
TreatHSP/SPAX: An adaptive natural history platform for SPAX diseases
This study tests a shared, long-term framework to track how SPAX diseases progress and to develop useful patient-centered outcome measures and biomarkers.
-
Noninvasive spinal stimulation to improve walking in hereditary spastic paraplegia
This trial will test whether noninvasive transcutaneous spinal cord stimulation can improve walking and reduce muscle stiffness in adults with hereditary spastic paraplegia.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Evaluating surgical treatment for foot deformities in hereditary spastic paraplegia
This study is testing how well surgery can help people with hereditary spastic paraplegia and foot deformities feel and function better over two years.
-
Exploring intrathecal baclofen treatment for hereditary spastic paraplegia
This study is testing if a special pump that delivers baclofen directly into the spine can help people with hereditary spastic paraplegia improve their movement and quality of life better than taking the medication by mouth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.